Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
Prev Story
Next Story
Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
1 reads
0 reactions
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
This story is currently in the Upcoming News queue because it received more dislikes than likes. Vote thumbs up to help promote it back to the Published homepage!
Browse Upcoming Feed
Same Story from Other Publications
Compare how 3 other independent news outlets reported on this story.
Jim Cramer on Nvidia scandal: Jensen Huang “let me down” | CNN
Jim Cramer of “Mad Money”, who knows Nvidia and Jensen Huang better than almost anyone, says Huang “let me down…he let his shareholders down.”
#cramer
Compare →
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
#drug
Compare →
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
#drug
Compare →
Related Stories
Technology
CNBC World
•
6h ago
CNBC World
•
9h ago
1 / 1